APA (7th ed.) Citation

Moulia, D. L., Link-Gelles, R., Chu, H. Y., Jamieson, D., Brooks, O., Meyer, S., . . . Jones, J. M. (2025). Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus– Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025. MMWR: Morbidity & Mortality Weekly Report, 74(32), 508. https://doi.org/10.15585/mmwr.mm7432a3

Chicago Style (17th ed.) Citation

Moulia, Danielle L., et al. "Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus– Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025." MMWR: Morbidity & Mortality Weekly Report 74, no. 32 (2025): 508. https://doi.org/10.15585/mmwr.mm7432a3.

MLA (9th ed.) Citation

Moulia, Danielle L., et al. "Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus– Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025." MMWR: Morbidity & Mortality Weekly Report, vol. 74, no. 32, 2025, p. 508, https://doi.org/10.15585/mmwr.mm7432a3.